Delivery of human factor IX in mice by encapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B

Blood

Volumn 87, Issue 12, 1996, Pages 5095-5103

  Hortelano, Gonzalo ^b   Al Hendy, Ayman ^b   Ofosu, Frederick A ^b   Chang, Patricia L ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BLOOD CLOTTING FACTOR 9; POLYLYSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GRAFT REJECTION; HEMOPHILIA B; MALE; MICROENCAPSULATION; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY;

EID: 0029890737     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5095.bloodjournal87125095     Document Type: Article

References (35)

1. Hedner U, Davie EW: Introduction to hemostasis and the vitamin K-dependent coagulation factors, in Scriber CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease, 5th ed. New York, NY, McGraw-Hill, 1989, p 207
2. Grossman M, Raper SE, Kozarsky K, Stein AE, Englehardt JF, Muller D, Lupien PJ, Wilson JM: Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 6:335, 1994
3. Chang PL: Nonautologous somatic gene therapy, in Chang PL (ed): Somatic Gene Therapy. Boca Raton, FL, CRC, 1995, p 203
4. Christensen L, Dionne KE, Lysaght MJ: Biomedical applications of immobilized cells, in Goosen MFA (ed): Fundamentals of Animal Cell Encapsulation and Immobilization. Boca Raton, FL, CRC, 1993, p 7
5. O'Shea G, Goosen MFA, Sun AM: Prolonged survival of transplanted islets of Langerhans encapsulated in a biocompatible membrane. Biochim Biophys Acta 804:133, 1984
6. Smidrod O, Skjak-Braek G: Alginate as immobilization matrix for cells. Tibtech 8:71, 1990
7. Sun A, Cai Z, Shi Z, Ma F, O'Shea G, Gharapetian H: Microencapsulated hepatocytes as a bioartificial liver. Trans Am Soc Artif Intern Organs 32:39, 1986
8. Chang TMS: Living cells and microorganisms immobilized by microencapsulation inside artificial cells, in Goosen MFA (ed): Fundamentals of Animal Cell Encapsulation and Immobilization. Boca Raton, FL, CRC, 1993, p 183
9. Winn S, Tresco P, Zielinski B, Greene L, Jaeger C, Aebischer P: Behavioral recovery following intrastriatal implantation of microencapsulated PC12 cells. Exp Neurol 113:322, 1991
10. Uludag H, Sefton MV: Metabolic activity and proliferation of CHO cels in HEMA-MMA microcapsules. Cell Transplant 35:1, 1992
11. Chang PL, Shen N, Wescott AJ: Delivery of recombinant gene products with microencapsulated cells in vivo. Hum Gene Ther 4:433, 1993
12. Liu H, Ofosu, FA, Chang PL: Expression of human factor IX by microencapsulated recombinant fibroblasts. Hum Gene Ther 4:291, 1993
13. Blau HM, Pavlath GK, Hardeman EC, Chiu CP, Silberstein L, Webster SB, Miller SC, Webster C: Plasticity of the differentiated state. Science 230:758, 1985
14. Al-Hendy A, Hortelano G, Tannenbaum GS, Chang PL: Correction of the growth defect in dwarf mice: A novel approach to somatic gene therapy. Hum Gene Ther 6:165, 1995
15. Yao SN, Kurachi K: Expression of human factor IX in mice after injection of genetically modified myoblasts. Proc Natl Acad Sci USA 89:3357, 1992
16. Chang PL: Calcium phosphate-mediated DNA transfection, in Wolff JA (ed): Gene Therapeutics. Boston, MA, Birkhauser Boston, 1994, p 157
17. Palmer TD, Thompson AR, Miller AD: Production of human factor IX in animals by genetically modified skin fibroblasts: Potential therapy for hemophilia B. Blood 73:438, 1989
18. Southern PJ, Berg P: Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Molec Appl Genet 1:327, 1984
19. Gunning P, Leavitt J, Muscat G, Sun-Yu N, Kedes L: A human β-actin expression vector system directs high-level accumulation of antisense transcript. Proc Natl Acad Sci USA 84:4831, 1987
20. Chang PL, Hortelano G, Tse M, Awrey D: Growth of recombinant fibroblasts in alginate microcapsules. Biotech Bioengin 43:925, 1994
21. Dai Y, Roman M, Naviaux R, Verma IM: Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA 89:10892, 1992
22. Roman M, Axelrod JH, Dai Y, Naviaux RK, Friedmann T, Verma IM: Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle. Somat Cell Mol Genet 18:247, 1992
23. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM: Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254:1509, 1991
24. Barr E, Leiden JM: Systemic delivery of recombinant proteins by genetically modified myoblasts. Science 254:1507, 1991
25. Gerrard AJ, Hudson DL, Brownlee GG, Watt FM: Towards gene therapy for haemophilia B using primary human keratinocytes. Nat Genet 3:180, 1993
26. Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhouse KM, Woo SLC: In vivo gene therapy of hemophilia B: Sustained partial correction in factor IX deficient dogs. Science 262:117, 1993
27. Dranoff G, Jaffee E, Lazemby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC: Vaccination with irradiated tumor cells enginnered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539, 1993
28. Yao SN, Wilson JM, Nabel EG, Kurachi S, Hachiya HL, Kurachi K: Expression of human factor IX in rat endothelial cells: Toward somatic gene therapy for hemophilia B. Proc Natl Acad Sci USA 88:8101, 1991
29. Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR, Read M, Brinkhous KM, Woo SLC: In vivo gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 91:2553, 1994
30. Smith TAG, Mehaffey MG, Kayda DB, Saunders JM, Yei S, Trapnell BC, McClelland A, Kaleko M: Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 4:397, 1993
31. Scharfmann R, Axelrod JH, Verma IM: Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc Natl Acad Sci USA 88:4626, 1991
32. Dwarki VJ, Belloni P, Nijjar T, Smith J, Couto L, Rabier M, Clift S, Berns A, Cohen LK: Gene therapy for hemophilia A: Production of therapeutic levels of human factor VIII in vivo in mice. Proc Natl Acad Sci USA 92:1023, 1995
33. Challita PM, Kohn DB: Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 91:2567, 1994
34. Soon-Shoing P, Heintz RE, Merideth N, Yao QX, Yao Q, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M, Mendez R, Sandford PA: Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343:950, 1994
35. Joseph JM, Heyd B, Favre J, Buchser E, Mosimann F, Goddard M, Aebischer P: Encapsulated bovine chromaffin cells xenotransplantation for the treatment of intractable pain: A phase I clinical study. J Cell Biochem Suppl 2B:6, 1995